BRIEF published on 05/07/2024 at 20:05, 1 year 11 months ago INSTALLUX S.A. annonce la mise à disposition de l'avis de convocation à l'AG Euronext Growth Paris Droits De Vote Assemblée Générale Informations Financières INSTALLUX S.A.
BRIEF published on 05/07/2024 at 20:05, 1 year 11 months ago INSTALLUX SA announces the availability of the notice of meeting for the AGM Euronext Growth Paris Voting Rights General Assembly INSTALLUX SA Financial Informations
BRIEF published on 05/07/2024 at 19:35, 1 year 11 months ago Assemblée Générale de JCDecaux SE : Approbation des Résolutions et Renouvellements de Mandats Assemblée Générale Gouvernance D'Entreprise Commissaires Aux Comptes Renouvellement De Mandat JCDecaux SE
BRIEF published on 05/07/2024 at 19:35, 1 year 11 months ago General Meeting of JCDecaux SE: Approval of Resolutions and Renewals of Mandates Corporate Governance General Assembly Auditors JCDecaux SE Renewal Of Mandate
BRIEF published on 05/07/2024 at 19:34, 1 year 11 months ago GenSight Biologics Announces Availability of Prospectus for New Shares Listing on Euronext Paris Euronext Paris Capital Increase Gene Therapy Prospectus GenSight Biologics
BRIEF published on 05/07/2024 at 19:34, 1 year 11 months ago GenSight Biologics annonce la mise à disposition d'un prospectus pour la cotation de nouvelles actions sur Euronext Paris Euronext Paris Augmentation De Capital Thérapie Génique Prospectus Produits Biologiques GenSight
BRIEF published on 05/07/2024 at 19:15, 1 year 11 months ago HiPay Group Announces Strong First Quarter Results for 2024 Revenue Growth Financial Outlook First Quarter 2024 Omnichannel Payments HiPay Group
BRIEF published on 05/07/2024 at 19:15, 1 year 11 months ago HiPay Group annonce de solides résultats pour le premier trimestre 2024 Hausse Des Revenus Perspectives Financières Premier Trimestre 2024 Paiements Omnicanaux Groupe HiPay
BRIEF published on 05/07/2024 at 19:15, 1 year 11 months ago Ajustement de la valeur nominale chez Pharnext Biopharmaceutique Réduction De Capital Valeur Nominale Pharnext Maladies Neurodégénératives
BRIEF published on 05/07/2024 at 19:15, 1 year 11 months ago Adjustment of the nominal value at Pharnext Biopharmaceutical Capital Reduction Pharnext Nominal Value Neurodegenerative Diseases
Published on 04/10/2026 at 19:20, 1 hour ago Lithium South Announces Closing of the Sale of Its Hombre Muerto North Lithium Project
Published on 04/10/2026 at 17:55, 2 hours 25 minutes ago Nepra Foods Inc. Reports Preliminary Unaudited Fiscal 2026 Fourth Quarter Revenue of $1.85 Million, Demonstrating Continued Growth Momentum
Published on 04/10/2026 at 14:45, 5 hours 35 minutes ago Secure Blockchain Completes Acquisition of Agentic Solutions Limited, Launches Enterprise Agentic AI Platform
Published on 04/10/2026 at 14:30, 5 hours 50 minutes ago Wi2Wi Corporation Announces Full Year 2025 Financial Results
Published on 04/10/2026 at 19:00, 1 hour 20 minutes ago EPIC Suisse AG – Annual General Meeting 2026 approves all proposals by the Board of Directors
Published on 04/10/2026 at 18:20, 2 hours ago Felicitysolar's Residential LiFePO4 Battery FLB48314TG1-H Wins 2026 Red Dot Design Award
Published on 04/10/2026 at 18:00, 2 hours 20 minutes ago Partners Group provides interim business update
Published on 04/10/2026 at 17:30, 2 hours 50 minutes ago Swiss Re shareholders approve all proposals at AGM 2026
Published on 04/10/2026 at 18:35, 1 hour 44 minutes ago Déclaration des transactions sur actions propres
Published on 04/10/2026 at 18:26, 1 hour 54 minutes ago EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE
Published on 04/10/2026 at 18:26, 1 hour 54 minutes ago EURAZEO ANNONCE LE SUCCÈS DE SON ÉMISSION OBLIGATAIRE INAUGURALE DE 500 MILLIONS D'EUROS
Published on 04/10/2026 at 18:00, 2 hours 20 minutes ago Declaration of voting rights at the end of March 2026
